Sintilimab in Cancer of Unknown Primary
Clinical trial NCT05024968 · COMPLETED
Trial details
- NCT number
- NCT05024968
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-26
- Primary completion
- 2025-04-03
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.